Rchr
J-GLOBAL ID：201801017838213217
Update date: Mar. 30, 2024
Taeang Arai
Taeang Arai
Affiliation and department：
Research field (1)：
Gastroenterology
Research keywords (1)：
肝疾患
Research theme for competitive and other funds (1)：
- 2021 - 2024 生態レドックス評価による早期NASH病態の解明と非侵襲的診断法の開発
Papers (114)：
-
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih-Wen Wang, Man-Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, et al. Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study. Journal of gastroenterology and hepatology. 2024
-
Hidenori Toyoda, Toshifumi Tada, Haruki Uojima, Akito Nozaki, Makoto Chuma, Koichi Takaguchi, Atsushi Hiraoka, Hiroshi Abe, Ei Itobayashi, Kentaro Matsuura, et al. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2024
-
Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, et al. Accuracy of the enhanced liver fibrosis test in patients with type 2 diabetes mellitus and its clinical implications. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023
-
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih-Wen Wang, Man-Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, et al. Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs. The Kaohsiung journal of medical sciences. 2023
-
Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, Kaori Koyano-Shioda, Tadamichi Kawano, Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, et al. How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis. JGH Open. 2023
ｍore...
MISC (186)：
-
大野弘貴, 河野惟道, 新井泰央, 吉田祐士, 大久保知美, 葉山惟信, 糸川典夫, 厚川正則, 岩切勝彦. 高脂血症合併NAFLD患者に対するペマフィブラートの肝病態に与える影響の検討. 日本消化器病学会雑誌(Web). 2022. 119
-
中村拳, 葉山惟信, 糸川典夫, 塩田香織, 大野弘貴, 河野惟道, 吉田祐士, 田邉智英, 大久保知美, 新井泰央, et al. 切除不能肝細胞癌に対するアテゾリツマブ+ベバシズマブ併用療法の初期治療経験. 日本消化器病学会雑誌(Web). 2022. 119
-
吉田祐士, 厚川正則, 塩田香織, 大野弘貴, 河野惟道, 田邊智英, 大久保知美, 葉山惟信, 金子恵子, 新井泰央, et al. C型肝炎患者におけるDAA治療後のSVR後肝発癌を予測するnew formulaの有用性. 日本消化器病学会雑誌(Web). 2022. 119
-
新井泰央, 厚川正則, 長谷川雄太, 大野弘貴, 河野惟道, 吉田祐士, 大久保知美, 岩下愛, 葉山惟信, 糸川典夫, et al. 2型糖尿病合併NAFLD患者における経口セマグルチドの肝病態改善効果の検証. 肝臓. 2022. 63. Supplement 1
-
糸川典夫, 厚川正則, 東哲之, 北村倫香, 塩田香織, 河野惟道, 大野弘貴, 吉田祐士, 田邊智英, 大久保知美, et al. B型肝炎患者の自然経過における肝線維化変化とHBs抗原量低下に寄与する因子の検討. 肝臓. 2022. 63. Supplement 1
ｍore...
Work history (4)：
- 2019/04 - 現在 Nippon Medical School
- 2018/04 - 2019/03 Nippon Medical School
- 2014/04 - 2018/03 Nippon Medical School
- 2012/04 - 2014/03 Nippon Medical School
Return to Previous Page
